Enanta Pharmaceuticals
ENTA
#7502
Rank
โ‚ฌ0.21 B
Marketcap
10,28ย โ‚ฌ
Share price
-2.23%
Change (1 day)
-13.00%
Change (1 year)

Revenue for Enanta Pharmaceuticals (ENTA)

Revenue in 2024 (TTM): โ‚ฌ66.72 M

According to Enanta Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is โ‚ฌ64.93 M. In 2023 the company made a revenue of โ‚ฌ66.59 M a decrease over the revenue in the year 2022 that were of โ‚ฌ76.53 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Enanta Pharmaceuticals from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ66.72 M0.19%
2023 โ‚ฌ66.59 M-12.98%
2022 โ‚ฌ76.53 M-6.35%
2021 โ‚ฌ81.72 M-1.72%
2020 โ‚ฌ83.15 M-50.31%
2019 โ‚ฌ0.16 B-19.6%
2018 โ‚ฌ0.20 B91.34%
2017 โ‚ฌ0.10 B127.72%
2016 โ‚ฌ47.76 M-60.45%
2015 โ‚ฌ0.12 B18.21%
2014 โ‚ฌ0.10 B2674.11%
2013 โ‚ฌ3.68 M-92.93%
2012 โ‚ฌ52.07 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ49.63 B 76,331.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ78.12 B 120,211.28%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.32 B 14,265.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ56.38 B 86,724.62%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ41.96 B 64,531.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ44.09 B 67,798.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland